Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filedlitigationCriticalhttps://patents.darts-ip.com/?family=39272765&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20071234(A1)"Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Biomarin Pharm IncfiledCriticalBiomarin Pharm Inc
Publication of PE20071234A1publicationCriticalpatent/PE20071234A1/es
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Abstract
REFERIDA A LA (6R)-L-ERITRO-TETRAHIDROBIOPTERINA (BH4), LA CUAL ES UTIL EN EL TRATAMIENTO DE TRASTORNOS CARDIOVASCULARES TALES COMO HIPERTENSION RECALCITRANTE, INSUFICIENCIA CARDIACA CONGESTIVA, ANEMIAS HEMOLITICAS, ENTRE OTRAS. LA BH4 SE PUEDE APLICAR POR VIA INTRAMUSCULAR, SUBCUTANEA O INTRAVENOSA EN UN RANGO DE 3MG/KG A 10 MG/KG POR DIA. DICHO COMPUESTO SE PUEDE ADMINISTRAR EN COMBINACION CON OTROS AGENTES FARMACEUTICOS TALES COMO UN INHIBIDOR DE LA FOSFODIESTERASA 5 (PDE 5), ENTRE OTROS
PE2007000113A2006-02-032007-02-01Composiciones a base de bh4 para el tratamiento de la enfermedad vascular
PE20071234A1
(es)
Novel 1,4-benzothiepin-1,1-dioxide derivatives which are substituted with benzyl groups, method for producing drugs containing said compounds and use thereof
Derivados de isoxazol, un proceso para su obtencion, composiciones farmaceuticas que los contienen y su uso en el tratamiento de enfermedades relacionadas con el receptor gaba aalfa5